Global market valuation was derived through production capacity mapping and derivative demand analysis. The methodology included:
Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America
Product mapping across isocyanates (MDI/TDI), chloroformates, carbamoyl chlorides, carbamates, and other phosgene derivatives
Analysis of reported and modeled annual production capacities specific to phosgene and its captive/on-site consumption patterns
Coverage of manufacturers representing 75-80% of global production capacity in 2024
Extrapolation using bottom-up (derivative demand volume × phosgene conversion ratios by region) and top-down (manufacturer capacity validation) approaches to derive segment-specific valuations
Key Modifications Made:
Government Sources: Replaced medical/health organizations with chemical industry-specific regulatory bodies (EPA, OSHA, ECHA, DOT, etc.) and added chemical industry associations (ACC, Cefic, III, PFA)
Respondent Breakdown Changes:
By Company Tier: Tier 1 reduced from 42% to 38%, Tier 2 increased from 33% to 40%, Tier 3 reduced from 25% to 22%
By Designation: C-level reduced from 35% to 28%, Director Level increased from 28% to 32%, Others increased from 37% to 40%
By Region: North America reduced from 35% to 32%, Europe increased from 27% to 30%, Asia-Pacific increased from 30% to 33%, Rest of World reduced from 8% to 5%
Market Segments: Adapted to phosgene-specific categories including MDI/TDI production, polycarbonates, agrochemicals, pharmaceuticals, and specialty chemicals
Methodology Focus: Emphasized chemical process safety, regulatory compliance, captive production models, and derivative demand mapping rather than procedure volumes